Home
/ Insights
/ Articles
/ How DME Suppliers Can Respond When Payment Issues Surface

How DME Suppliers Can Respond When Payment Issues Surface

In the broader context of healthcare spending, overpayments related to durable medical equipment (“DME”) such as wheelchairs or respiratory therapy devices (e.g., ventilators and associated supplies), may seem relatively minor on a claim-by-claim basis. However, when a recent Office of Inspector General audit found that Medicare improperly paid suppliers $22.7 million over seven years, it demonstrated how modest discrepancies can accumulate and underscored the need for processes to identify and resolve overpayments.1

For many Americans, DME is simply a part of daily life: from a CPAP machine that helps a family member finally get a good night’s sleep to a walker that supports mobility after a hip replacement. Most patients never think twice about the highly complex ecosystem of processes, billing codes, coverage rules and documentation requirements associated with their DME, but DME suppliers know all too well that small gaps in documentation, coding and supplier workflows can result in widespread denials or improper payments.

There’s no simple solution for overpayment risk in DME because it rarely stems from a single failure point. Instead, it is often driven by breakdowns across fragmented and multi-party workflows, where patient status, documentation and billing processes can become misaligned. These disconnects can trigger duplicate billing, claim denials and repayment obligations. More importantly, such billing issues increase the risk of regulatory oversight and erode stakeholder confidence.

For DME suppliers, finding these failure points is challenging because they often span multiple functions and systems. Without a holistic, end-to-end view of the DME lifecycle, incremental fixes will only mask symptoms rather than address underlying issues.

While DME overpayments likely aren’t going away, forward-looking DME suppliers are operationalizing this data to reduce future exposure. How can DME suppliers leverage overpayment insights to strengthen documentation controls, refine account triage frameworks and identify recurring denial patterns to manage risk more proactively?

Key Issues Driving Denials and Repayments

Behind every repayment exposure lies a recurring set of breakdowns that surface in denial patterns – most commonly, documentation and process-management gaps. While these issues may appear complex, they typically stem from a small number of process-level weaknesses that compound over time. These include:

Patient Visibility Gaps
Limited visibility into patient status presents a significant challenge for DME suppliers. For example, suppose Mr. Smith uses a CPAP machine at home and is unexpectedly hospitalized. During his inpatient stay, the hospital may provide him with a CPAP machine for use while admitted. Under Medicare, DME furnished to a beneficiary during an inpatient stay is considered bundled into the facility’s inpatient prospective payment, which comes from Medicare Part A. Mr. Smith’s home CPAP is reimbursed through the Medicare Part B benefit and is not reimbursed at the same time as Part A. Without real-time access to patient status, even a diligent DME supplier may unknowingly submit a claim for equipment that overlaps with an active inpatient stay, creating compliance exposure that is difficult to detect and prevent without the right tools and data infrastructure in place.

Timing and Documentation Misalignment
DME suppliers operate within a tightly sequenced workflow in which they receive physician orders and evaluate them against regulatory standards, medical necessity criteria and patient coverage requirements before providing DME to a patient.

This creates a complex “order of operations” challenge. These requirements must align with real-time patient activity, yet they rarely do. Delays in documentation or incomplete records can create disconnects between delivery and billing eligibility windows. Likewise, changes in patient status – such as inpatient admission – can render previously valid claims ineligible.

Although these timing mismatches may seem minor, their downstream impact can cause headaches. Processes that appear sound at the point of service often fail retrospective review, when documentation, coverage periods and patient status are reconciled. This results in denials, disputes and repayment exposure.

Back-End Reconciliation Weaknesses
Many organizations rely on payer denials to surface billing issues, rather than proactively identifying them through analytics. As a result, problems are often discovered only after claims are rejected.

Building proactive controls is inherently complex. DME suppliers often operate with siloed processes and limited visibility across the revenue cycle, which limits their ability to identify systemic issues early. In many cases, revenue cycle management remains reactive and functions as a back-office process rather than a strategic driver.

Limited infrastructure can hamper the efficient tracking, refunding and resolution of overpayments, thereby prolonging exposure and increasing the administrative burden. A DME supplier may also lack the proper internal controls or analysts who fully understand billing complexities and regulatory changes. For example, many DME devices are reimbursed monthly as rentals, but the specific regulations can vary by state and by payer (e.g., total rental period, required continued contact with the patient over the course of the rental, etc.). This web of regulations can be difficult to manage with limited infrastructure.

DME suppliers can invest in infrastructure and leverage data analytics to mitigate these issues. For example, sophisticated DME suppliers maintain and continually refresh an internal database containing the relevant contract terms, including key reimbursement rules and expected payment rates. This database is overlaid against the DME suppliers’ claim activity to proactively identify likely denials and retrospectively identify payer overpayments. This allows DME suppliers to improve revenue cycle and proactively address overpayment issues before they become larger compliance inquiries.

Incremental Improvements Mask but Don’t Reduce Risk

Addressing these challenges in isolation will yield only incremental improvement. To meaningfully reduce risk, DME suppliers should look to adopt an integrated, end-to-end approach that aligns patient visibility, documentation and billing processes throughout the lifecycle. Even if eliminating all overpayments and denial claims is not feasible, DME suppliers should better understand the underlying causes and how to remediate them. The key for DME suppliers is to move beyond awareness to practical risk identification.

Before Billing: Managing What You Don’t Know

Many DME suppliers assume that payment risk begins when a claim is submitted. In practice, it often begins much earlier, when a patient's status changes and that information never makes its way to the supplier. A beneficiary may be admitted unexpectedly, have a discharge date pushed back, or transition between care settings without anyone notifying the DME provider. By the time equipment is delivered, the supplier may be acting on information that was accurate when the order was received but no longer reflects the patient's actual situation.

For that reason, some of the most effective risk-reduction strategies are surprisingly simple. Rechecking eligibility before billing, establishing communication pathways with key referral sources, and paying close attention to orders associated with recent hospital discharges can help identify issues before they become payment problems. The goal is not to create perfect visibility, but to reduce the number of situations in which a supplier is making decisions with outdated information.

After Payment: Using Data To Look for Patterns, Not Individual Errors

Many organizations treat denials, recoupments and audit findings as isolated events. The more useful approach is to view them as data points. A single inpatient overlap may be unavoidable; a recurring pattern involving the same referral source, product category, or patient transition point may signal a process issue that deserves attention.

The suppliers that manage payment risk most effectively are often those that routinely step back and use their own data to look for trends. They review why claims are being adjusted months after payment, identify where breakdowns most commonly occur, and use those insights to refine front-end processes and identify compliance risks. In many cases, the greatest value comes not from preventing a specific overpayment but from recognizing a pattern early enough to prevent dozens more. After Identification: Response Matters As Much as Prevention.

After Identification: Response Matters As Much as Prevention

No matter how strong a supplier's processes are, some payment issues will only come to light after the fact. When they do, the quality of the response becomes just as important as the underlying issue. Regulators and auditors understand that suppliers operate with imperfect information, and they may place significant weight on how organizations investigate, document and resolve identified overpayments.

A well-defined response process may significantly reduce compliance risk. This could include promptly evaluating potential overpayments, maintaining clear records of investigative steps, submitting refunds when appropriate, and documenting corrective actions. Organizations with focused efforts and documented processes around identification, investigation and corrective action are generally better prepared to respond effectively to both routine repayment situations and broader compliance inquiries.

Footnotes:

1: U.S. Department of Health and Human Services, Office of Inspector General, “Medicare Improperly Paid Suppliers $22.7 Million Over 7 Years for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies Provided to Enrollees During Inpatient Stays,” (Oct. 28, 2025).

2: See “DMEPOS Payments for Inpatient Stays” on CMS.gov.